Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-01

Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Clonidine Extended-Release OnydaTM XR in Children With ADHD and ODD [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study to assess the effectiveness and safety of clonidine extended-release Onyda XR in children with attention-de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONYDA XR (CLONIDINE HYDROCHLORIDE)

Snippet

Sponsor: Las Vegas Medical Research, LLC DBA Vector Clinical Trials | Conditions: Attention-deficit/Hyperactivity Disorder, Oppositional Defiant Disorder in Children | Phase 4 | Status: NOT_YET_RECRUITING